Moreover, the percentage of FOXP3+ cells within the CD4+CD127low T-cell population was always higher than within the CD4+CD25high population, suggesting that previous data only assessing a CD4+CD25high phenotype have underestimated the absolute increase of FOXP3+ Treg cells in cancer patients (Tables 3 and 4). Here, FOXP3 is linked to cancer.